S&P 500
7,741.22
-6.49
-0.08%
Dow
53,577.47
-108.64
-0.20%
Nasdaq
26,588.06
+4.00
+0.02%
NYSE Composite
24,623.80
-96.35
-0.39%
Russell 2000
2,953.27
-15.01
-0.51%
VIX
14.10
-0.22
-1.54%
OSCR · Oscar Health, Inc.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Oscar Health Inc (OSCR)
NEW YORK STOCK EXCHANGE, INC.
Insurance
$31.95
-0.28
(-0.87%)
● Market open
DAY'S RANGE
$31.95
$31.89
$32.19
52-WEEK RANGE
$31.95
$10.69
$33.55
What's happening
- OSCR is down 0.87% today, trading at $31.95. — Live quote
- Volume today (7,469) is well below its 3-month average of 6,626,490. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $1.10 actual vs. $0.39 estimated (+179.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 7
Hold 9
Sell 1
Strong sell 0
Aggregate ratings for 2026-09-01 (19 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
OSCR
+111.06%
vs S&P 500
+98.86%
1-YEAR RETURN
OSCR
+71.55%
vs S&P 500
+52.69%
6-MONTH RETURN
OSCR
+122.36%
3-MONTH RETURN
OSCR
+43.47%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-08-06 (Q2 2026)
$1.10
Est. $0.39
BEAT +179.5%
2026-04-26 (Q1 2026)
$2.07
Est. $1.21
BEAT +71.5%
2026-01-26 (Q4 2025)
$-1.24
Est. $-0.91
MISS -37.0%
2025-10-26 (Q3 2025)
$-0.53
Est. $-0.57
BEAT +6.6%
Valuation Measures & Ratios
Enterprise Value4$6.08B
Forward P/E518.70
PEG Ratio6—
Price / Sales (TTM1)0.63
Price / Book74.19
EV4 / Revenue0.40
EV4 / EBITDA9.23
Profit Margin3.60%
Operating Margin4.11%
Return on Equity (ROE8)38.53%
Return on Assets (ROA9)6.76%
Avg Volume (3M)6,626,490
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $9.39B | $3.76B | $4.91B | $5.51B | $3.92B |
| P/E | 13.91 | 6.39 | -33.83 | 113.48 | 8.63 |
| Price/Sales | 0.61 | 0.28 | 0.43 | 0.52 | 0.40 |
| Price/Book | 4.57 | 2.26 | 4.79 | 4.75 | 2.94 |
| EV/Revenue | 0.37 | -0.05 | 0.30 | 0.30 | 0.20 |
| EV/EBITDA | 7.55 | -0.91 | -41.79 | — | — |
| ROE | 32.89% | 35.37% | -14.17% | 4.19% | 34.08% |
| ROA | 6.01% | 6.33% | -2.53% | 0.76% | 7.77% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short16,438,924
Change from Prior Settlement-7.78%
% of Float—
Days to Cover (Short Ratio)2.34
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 70.4% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +71.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 3.6%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-31; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on OSCR
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.99B | $2.86B | $3.05B | $2.42B | $2.22B | $2.14B |
| Operating income | $388.6M | $704.1M | -$129.2M | -$230.5M | $297.1M | -$48.4M | $67.8M | $185.6M |
| Net income | $361.8M | $679.0M | -$137.4M | -$228.4M | $275.3M | -$54.6M | $56.2M | $177.4M |
| EPS (diluted) | $1.10 | $2.07 | $-0.53 | $-0.89 | $0.92 | $-0.22 | $0.20 | $0.62 |
| EPS (basic) | $1.20 | $2.28 | $-0.53 | $-0.89 | $1.10 | $-0.22 | $0.24 | $0.77 |
| Operating margin | $8 | $15 | -$4 | -$8 | $10 | -$2 | $3 | $9 |
| Net margin | $7 | $15 | -$5 | -$8 | $9 | -$2 | $3 | $8 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B |
| Total liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B |
| Stockholders' equity | $2.05B | $1.66B | $977.6M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B |
| Total current assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B |
| Total current liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B |
| Cash & equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B |
| Marketable securities (current) | — | — | — | — | — | — | $624.5M | — |
| Accounts receivable | $380.1M | $587.0M | $362.7M | — | — | — | — | — |
| Other current assets | $60.3M | $25.8M | $24.3M | $28.6M | $30.5M | $23.0M | $21.3M | $20.7M |
| Marketable securities (non-current) | — | — | — | — | — | — | $1.82B | — |
| Property, plant & equipment | $101.5M | $94.2M | $88.3M | $83.4M | $77.7M | $72.0M | $66.8M | $66.6M |
| Other non-current assets | $122.1M | $122.7M | $119.7M | $120.6M | $116.3M | $93.6M | $82.4M | $84.4M |
| Long-term debt | $431.6M | $430.9M | $430.1M | $686.3M | $299.9M | $299.7M | $299.6M | $299.4M |
| Other non-current liabilities | $50.5M | $51.4M | $52.0M | $55.8M | $57.3M | $59.3M | $61.3M | $63.5M |
| Common stock & paid-in capital | — | — | — | — | — | — | — | — |
| Retained earnings | -$2.25B | -$2.62B | -$3.29B | -$2.94B | -$2.80B | -$2.58B | -$2.85B | -$2.70B |
| Accumulated other comprehensive income (loss) | -$8.2M | $5.0M | $18.0M | $16.4M | $13.7M | $9.6M | -$1.8M | $26.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.09B | $2.62B | $671.9M | -$964.7M | $509.1M | $878.5M | $346.8M | -$500.1M |
| Investing cash flow | -$2.83B | -$590.3M | -$48.7M | $150.1M | -$168.2M | -$174.2M | -$31.4M | -$577.8M |
| Financing cash flow | $13.3M | -$3.6M | $8.2M | $364.0M | $22.1M | $4.9M | $3.8M | $18.6M |
| Depreciation & amortization | $6.0M | $7.0M | $7.9M | $7.3M | $7.0M | $6.7M | $9.2M | $7.5M |
| Share-based compensation | $20.7M | $16.0M | $18.1M | $20.5M | $24.1M | $25.0M | $25.9M | $29.3M |
| Deferred income taxes | -$1.5M | -$6.2M | $2.6M | -$175.0K | -$36.0K | $36.0K | -$2.3M | -$119.0K |
| Change in accounts receivable | -$158.8M | $224.3M | — | — | -$46.2M | $97.8M | — | — |
| Purchases of investments | $4.03B | $914.8M | $233.2M | $172.8M | $271.0M | $336.9M | $110.5M | $660.1M |
| Sales/maturities of investments | $948.9M | $35.0M | $0 | $118.5M | $0 | $15.8M | $4.1M | $21.2M |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | $0 | $410.0M | — | — | $0 | $0 |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $11.9M | $0 | $0 | $1.7M | $1.4M | $855.0K | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Operating income | -$396.4M | $57.3M | -$235.6M | -$589.9M | -$544.5M |
| Net income | -$443.2M | $25.4M | -$270.7M | -$606.3M | -$572.6M |
| EPS (diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| EPS (basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 |
| Operating margin | -$3 | $1 | -$4 | -$15 | -$30 |
| Net margin | -$4 | $0 | -$5 | -$15 | -$31 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B |
| Stockholders' equity | $977.6M | $1.01B | $804.0M | $890.4M | $1.39B |
| Total current assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B |
| Total current liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B |
| Cash & equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B |
| Marketable securities (current) | — | $624.5M | $689.8M | — | — |
| Other current assets | $24.3M | $21.3M | $6.6M | $6.5M | $3.8M |
| Marketable securities (non-current) | — | $1.82B | $365.3M | — | — |
| Property, plant & equipment | $88.3M | $66.8M | $61.9M | $59.9M | $46.6M |
| Other non-current assets | $119.7M | $82.4M | $83.3M | $94.8M | $96.6M |
| Long-term debt | $430.1M | $299.6M | $298.8M | $298.0M | $0 |
| Other non-current liabilities | $52.0M | $61.3M | $67.6M | $72.3M | $76.8M |
| Common stock & paid-in capital | — | — | — | — | — |
| Retained earnings | -$3.29B | -$2.85B | -$2.88B | -$2.61B | -$2.00B |
| Accumulated other comprehensive income (loss) | $18.0M | -$1.8M | $1.3M | -$9.7M | -$3.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $978.2M | -$272.2M | $380.3M | -$181.7M |
| Investing cash flow | -$241.1M | -$1.39B | $577.2M | -$226.5M | -$774.5M |
| Financing cash flow | $399.2M | $68.4M | $6.4M | $301.1M | $1.24B |
| Depreciation & amortization | $28.9M | $32.1M | $30.7M | $15.3M | $14.6M |
| Share-based compensation | $87.7M | $109.8M | $159.7M | $112.3M | $86.3M |
| Deferred income taxes | $2.4M | -$2.3M | $58.0K | -$165.0K | -$101.0K |
| Purchases of investments | $1.01B | $2.13B | $837.0M | $1.19B | $1.81B |
| Sales/maturities of investments | $134.2M | $25.2M | $31.9M | $360.6M | $624.1M |
| Other investing activities | — | — | — | — | $0 |
| Share repurchases | — | — | — | — | $0 |
| Debt issued | $410.0M | $0 | $0 | $305.0M | $0 |
| Debt repaid | — | — | $0 | $0 | $153.2M |
| Tax withholding on stock comp | $4.0M | $0 | $0 | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding OSCR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-14 to 2026-08-28
Recent transactions
- Insiders have net sold 4,588,716 shares over the last 182 days, across 0 purchases and 39 sales.
- Most recent: Schlosser Mario (Director) — Derivative conversion of 150,000 shares on 2026-08-28.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)4,588,716 sh(39 txns)
Net Shares-4,588,716
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Schlosser Mario | Director | Derivative conversion | 2026-08-28 | 150,000 |
| Blackley Richard Scott | Chief Financial Officer | Open market sale | 2026-08-18 | 18,750 |
| Bertolini Mark T | Chief Executive Officer | Open market sale | 2026-06-30 | 488,654 |
| Lang Laura W | Director | Grant / award | 2026-06-04 | 8,475 |
| Plouffe David | Director | Grant / award | 2026-06-04 | 8,475 |
| Sankaran Sid | Director | Grant / award | 2026-06-04 | 8,475 |
| Gassen William | Director | Grant / award | 2026-06-04 | 8,475 |
| WITTMAN VANESSA AMES | Director | Grant / award | 2026-06-04 | 8,475 |
| Baltrus Victoria | Chief Accounting Officer | Open market sale | 2026-06-02 | 1,091 |
| McAnaney Adam | Chief Legal Officer | Open market sale | 2026-06-02 | 7,065 |
| Liang Janet | President, Oscar Insurance | Open market sale | 2026-06-02 | 8,940 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-28 | Schlosser Mario | Director | Derivative conversion | 150,000 | — |
| 2026-08-28 | Schlosser Mario | Director | Open market sale | 150,000 | $30.79 |
| 2026-08-27 | Schlosser Mario | Director | Derivative conversion | 600,000 | — |
| 2026-08-27 | Schlosser Mario | Director | Open market sale | 600,000 | $30.34 |
| 2026-08-18 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 18,750 | $31.74 |
| 2026-07-01 | Schlosser Mario | Director | Derivative conversion | 47,500 | — |
| 2026-07-01 | Schlosser Mario | Director | Open market sale | 3,600 | $29.50 |
| 2026-07-01 | Schlosser Mario | Director | Open market sale | 13,672 | $30.80 |
| 2026-07-01 | Schlosser Mario | Director | Open market sale | 30,228 | $31.65 |
| 2026-06-30 | Bertolini Mark T | Chief Executive Officer | Open market sale | 488,654 | $28.35 |
| 2026-06-30 | Bertolini Mark T | Chief Executive Officer | Open market sale | 135,590 | $28.97 |
| 2026-06-29 | Bertolini Mark T | Chief Executive Officer | Open market sale | 555,826 | $29.17 |
| 2026-06-29 | Bertolini Mark T | Chief Executive Officer | Open market sale | 58,926 | $30.08 |
| 2026-06-26 | Bertolini Mark T | Chief Executive Officer | Open market sale | 441,373 | $29.11 |
| 2026-06-26 | Bertolini Mark T | Chief Executive Officer | Open market sale | 149,795 | $29.79 |
| 2026-06-25 | Bertolini Mark T | Chief Executive Officer | Open market sale | 597,942 | $28.60 |
| 2026-06-25 | Bertolini Mark T | Chief Executive Officer | Open market sale | 17,200 | $29.08 |
| 2026-06-23 | Schlosser Mario | Director | Derivative conversion | 880,000 | — |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 286,988 | $28.95 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 591,213 | $29.58 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 1,799 | $30.09 |
| 2026-06-23 | Schlosser Mario | Director | Derivative conversion | 50,000 | — |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 16,307 | $28.95 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 33,591 | $29.58 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 102 | $30.09 |
| 2026-06-23 | Schlosser Mario | Director | Derivative conversion | 50,000 | — |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 16,306 | $28.95 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 33,592 | $29.58 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 102 | $30.09 |
| 2026-06-23 | Schlosser Mario | Director | Derivative conversion | 47,500 | — |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 15,491 | $28.95 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 31,912 | $29.58 |
| 2026-06-23 | Schlosser Mario | Director | Open market sale | 97 | $30.09 |
| 2026-06-04 | Lang Laura W | Director | Grant / award | 8,475 | $0.00 |
| 2026-06-04 | Plouffe David | Director | Grant / award | 8,475 | $0.00 |
| 2026-06-04 | Sankaran Sid | Director | Grant / award | 8,475 | $0.00 |
| 2026-06-04 | Gassen William | Director | Grant / award | 8,475 | $0.00 |
| 2026-06-04 | WITTMAN VANESSA AMES | Director | Grant / award | 8,475 | $0.00 |
| 2026-06-02 | Baltrus Victoria | Chief Accounting Officer | Open market sale | 1,091 | $21.74 |
| 2026-06-02 | Baltrus Victoria | Chief Accounting Officer | Open market sale | 432 | $22.45 |
| 2026-06-02 | Schlosser Mario | Director | Open market sale | 24,452 | $21.74 |
| 2026-06-02 | Schlosser Mario | Director | Open market sale | 9,668 | $22.45 |
| 2026-06-02 | McAnaney Adam | Chief Legal Officer | Open market sale | 7,065 | $21.74 |
| 2026-06-02 | McAnaney Adam | Chief Legal Officer | Open market sale | 2,794 | $22.45 |
| 2026-06-02 | Liang Janet | President, Oscar Insurance | Open market sale | 8,940 | $21.74 |
| 2026-06-02 | Liang Janet | President, Oscar Insurance | Open market sale | 3,535 | $22.45 |
| 2026-06-02 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 22,706 | $21.74 |
| 2026-06-02 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 8,977 | $22.45 |
| 2026-05-18 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 110,000 | $25.03 |
| 2026-05-14 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 91,259 | $23.10 |
| 2026-05-14 | Blackley Richard Scott | Chief Financial Officer | Open market sale | 8,741 | $23.79 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-04 13:35 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-31 | 4 | 2026-08-27 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-13 | 4 | 2026-07-09 | View on SEC.gov → |
| 2026-07-13 | 4 | 2026-07-09 | View on SEC.gov → |
| 2026-07-13 | 4 | 2026-07-09 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-29 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-25 | View on SEC.gov → |
| 2026-06-25 | 4 | 2026-06-23 | View on SEC.gov → |
| 2026-06-09 | 8-K | 2026-06-04 | View on SEC.gov → |
Recent news
Headlines about OSCR (Oscar Health, Inc.). Links open the publisher — we don’t host full articles.
-
Oscar Health (NYSE:OSCR) Displays High Growth Momentum With a Defined Breakout Setup
ChartMill · 2026-09-04 -
Best Growth Stocks to Buy for September 4th
Yahoo Finance · 2026-09-04 -
Oscar Health, Inc. (NYSE:OSCR) Given Average Recommendation of "Hold" by Analysts
MarketBeat · 2026-09-04 -
Oscar Health (NYSE: OSCR) officer plans $286K stock sale
Stock Titan · 2026-09-03 -
Oscar Health (NYSE: OSCR) insider plans new stock sale
Stock Titan · 2026-09-03 -
Oscar Health (OSCR) holder lines up $326K stock sale
Stock Titan · 2026-09-03 -
Oscar Health (NYSE: OSCR) officer plans $908K Rule 144 share sale
Stock Titan · 2026-09-03 -
2 Small-Cap Stocks with Exciting Potential and 1 We Avoid
Yahoo · 2026-09-03
No headlines in this category right now — try “All”.